Cancer & Disease Research
Rare cancer study identifies patients at high risk of metastasis
A large genomic study of a rare cancer called metastatic pheochromocytoma identified patients at high risk of metastasis, as well as those most likely to respond to immunotherapy. The results, published in Nature Communications on February 28, may allow closer following up of patients with poor prognoses, and facilitate more personalized treatments. Read More
Video from AACC: Lab Ordering Cloud software
Mehdi Maghsoodnia, CEO of 1health, spoke to's sister site about the market needs for the firm’s Lab Ordering Cloud, as well as diagnostic industry trends. Read More
Science Briefs
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter